Since 1998, Kreos Capital has committed in excess of €7.0 billion across 830+
transactions, to more than 640 pan-European and Israeli high-growth companies
in the technology and healthcare sectors.
Today, we invest more than €800m a year and continue to enhance our product
offering and presence in the markets.
Kreos Capital
27+
years in business
8
funds in operation
830+
deals completed
$7B+
committed
Source: Kreos Capital / BlackRock Growth Debt. Data as of Q3’25
About
A Growth Debt pioneer
Kreos Capital has been a consistent growth partner of choice, providing clarity and continuity for both management teams and equity sponsors looking for a long-term finance partners willing to share our long-time goals.
In August 2023, Kreos Capital was acquired by BlackRock, Inc. All Kreos employees transitioned to BlackRock’s Private Markets platform, where they continue to operate the same Growth Debt strategy.
Extensive experience and investment history in technology and healthcare
Kreos Capital provides financing for companies across the wide spectrum of the Technology and Healthcare sectors. In Technology, we have invested across fintech, enterprise software, cybersecurity, semiconductors, digital marketing, AI and other sub-sectors, while in Healthcare, we have backed companies in areas such as drug and treatment development, medical products and devices, and healthcare tech.
Successful track record
Kreos Capital has built its reputation through an unwavering support for all of our portfolio companies during multiple business cycles. We rely on our close and mutually beneficial working relationships with both our equity sponsor partners and management teams, and they can rely on us to through every stage of the economic cycle. That is why we are widely recognised throughout the industry as a preferred choice when partners are really needed.
Support for every stage
Kreos Capital has the experience and resources to support high-growth companies through every stage of their growth life cycle, from entry-level growth and mid-stage development, through to late stage and pre-IPO / exit funding, as well as publicly listed growth funding.
Broad geographical reach across Europe and Israel
Since pioneering our investment strategy more than 27 years ago, Kreos Capital has grown to become the leading growth debt provider in our target regions, with broad coverage and transaction history across Europe and Israel.
Kreos Capital is one of the only lenders that can offer both local support and international coverage having invested in 22 countries and across a wide array of sectors.
Flexible, tailored approach
At Kreos Capital, we understand that true innovation requires adaptable and responsive financing. With significant financial backing from blue-chip institutional investors, robust infrastructure, and large, experienced investment team, Kreos has consistently provided debt facilities that match the ever evolving needs of high-growth companies.
Our Portfolio
Kreos Capital has provided finance in more than 830 transactions to more than 550 high-growth companies since inception. Our portfolio represents an extremely well-diversified cross section of investments across the European and Israeli growth market.
Our Team
Headquartered in London, Kreos Capital’s core team has been in place since 1998 and is led by seven partners with combined experience in excess of 150 years.
With a further presence in Sweden and Israel, an experienced investment team and a wellresourced finance and operations team, Kreos Capital is well positioned to maintain its role as a market leading provider of finance for pan-European and Israeli growth companies.
EPM0426-5430877-EXP0427